Systematic Reviews and Meta-Analysis Multiple systematic reviews and meta-analyses have evaluated the efficacy and safety of oral 600 mg/day ALA in treating DPN, showing significant improvements in neuropathic pain and NCV [110]
Results from this trial showed that Miplyffa, in combination with miglustat, halted disease progression through 12 months of treatment, as evidenced by a decrease of 0.2 points from baseline on the rescored 4-domain NPC Clinical Severity Scale
10.1016/j.clnu.2013.01.014 24 BhatS.RiederF
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
They will ask you about your medical history, concerns, and goals to determine which option will be most effective for you
LL-37 is present in the nasal lining, and levels can rise in inflamed nasal tissue